-
1 Comment
Chongqing Sansheng Industrial Co.,Ltd is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 80.1% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.8.
Chongqing Sansheng Industrial Co.,Ltd's total revenue sank by 1.7% to $709M since the same quarter in the previous year.
Its net income has dropped by 57.3% to $2M since the same quarter in the previous year.
Finally, its free cash flow fell by 176.0% to $-49M since the same quarter in the previous year.
Based on the above factors, Chongqing Sansheng Industrial Co.,Ltd gets an overall score of 1/5.
| ISIN | CNE100001WZ4 |
|---|---|
| CurrencyCode | CNY |
| Exchange | SHE |
| Sector | Basic Materials |
| Industry | Building Materials |
| Market Cap | 2B |
|---|---|
| Beta | 0.36 |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Chongqing Sansheng Industrial Co.,Ltd. develops, produces and sells building materials and chemicals in China and internationally. It operates through two segments, Buildings Materials Chemical Industry; and Pharmaceutical Manufacturing. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy, and hydropower; sulfuric acid for the production of fertilizers, chemicals, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises; and concrete admixtures. It also provides pharmaceutical products comprising intermediates, such as procaine hydrochloride, cefoxitin acid intermediates, chlorine intermediates, chloramphenicol intermediates, aztreonam intermediates, and orlistat intermediates for use as antibiotic drugs, anti-hepatitis C drugs, diabetes drugs, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; and API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benolate, and diphenhydramine hydrochloride. In addition, the company offers preparation products, such as compound paracetamol diphenhydramine, cloperidine hydrochloride, clarithromycin sustained-release, diclofenac sodium enteric-coated, acetaminophen, and famotidine tablets, which are used for antipyretic and analgesic, anti-inflammatory viruses, antibacterial, cough, allergy, and local anesthesia, as well as famotidine, diclofenac sodium, nifedipine, sodium nitrate, acetaminophen, furosemide, and norfloxacin drugs. Further, it provides solid preparation, large infusion, and small volume parenteral pharmaceutical products. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. Chongqing Sansheng Industrial Co.,Ltd. was incorporated in 2002 and is headquartered in Chongqing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002742.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
